STIM Neuronetics, Inc.

$1.22 +0.41%

Healthcare · Surgical & Medical Instruments & Apparatus

Neuronetics, Inc. (STIM) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $85 million. Shares last traded at $1.22, 74.8% below their 52-week high. Over the past year the stock is down 65.0%. Net profit margin is -26.1%, below the peer median of -7.6%. Revenue grew 99.2% year over year.

Market Cap

$85M

Shares Out

69.6M

EPS (TTM)

$-1.22

P/E Ratio

—

P/S Ratio

0.57

P/B Ratio

6.40

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.83

52-Week Low

$0.81

Volume

77,712

Avg Vol (3m)

84,787.238

Performance

-7.58%

+2.95%

-19.47%

-26.28%

YTD

-15.28%

-64.99%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

42.51

SMA (50)

$1.47

SMA (200)

$1.87

Price vs SMA50

-17.00%

Price vs SMA200

-34.59%

ATR (14)

$0.13

Financials

Revenue

$149M

Net Income

$-39M

Gross Margin

48.5%

Operating Margin

-21.1%

Net Margin

-26.1%

Return on Equity

-294.0%

Return on Assets

-31.1%

Current Ratio

1.67

Debt / Equity

4.62

Revenue Growth (YoY)

+99.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.16	2026-05-05
FY 2025	$-0.59	2026-03-17
Q3 2025	$-0.49	2025-11-04
Q2 2025	$-0.36	2025-08-05
Q1 2026	$-0.21	2026-05-05
FY 2025	$-1.38	2026-03-17

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

STIM vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

0.57 / 2.52 med

-77% discount

Net margin vs peers

-26.1% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.